Quality Reforms, Biopharma Ecosystem Top Priority to Keep India as ‘Pharmacy of World’: Pharma Secy Manoj Joshi
July 30, 2026
From implementation of revised schedule M norms to tighter regulatory oversight and efforts to improve manufacturing, Manoj Joshi, Secretary, Department of Pharmaceuticals, in an interview with businessline covered the government’s roadmap to strengthen India’s pharmaceutical sector amid concerns over drug quality, export scrutiny and rising medicine costs. …
Original URL: Click here to visit original article


